Printer Friendly

ROBERTS PHARMACEUTICAL CORPORATION ELECTS NEW DIRECTOR

ROBERTS PHARMACEUTICAL CORPORATION ELECTS NEW DIRECTOR
    EATONTOWN, N.J., Sept. 30 /PRNewswire/ -- Roberts Pharmaceutical Corporation (NASDAQ: RPCX) announced today the election of W. Robert Fowler, M.D. to its board of directors; thereby increasing the number of directors on the Roberts board from eight to nine.  Dr. Fowler has over 30 years of extensive experience in general surgery, has a decorated military career and has been the recipient of numerous achievements and academic appointments in his field of expertise.
    Dr. Fowler received his undergraduate degree in chemistry from the University of North Carolina and received his medical degree from Duke University.  He served as Chief Resident, General Surgery at the University of Tennessee at Chattanooga and then went on to serve a Fellowship in General Surgery at the Lahey Clinic in Boston.
    Dr. Fowler served as the chairman of the Surgical Education Department and a member of the teaching staff at Baroness Erlanger Hospital in Chattanooga, Tenn., from 1958 to 1980, concurrently developing a successful private practice in general surgery until 1984. Dr. Fowler has also served on the executive committees and board of directors of numerous hospitals and organizations including Hospital Corporation of America, Reid-Rowell Laboratories from 1972 to 1986; W.E. Hauck, Inc. (acquired by Roberts earlier this year) and founder, first chief of staff and chairman of the board of Parkridge Hospital in Chattanooga.
    Dr. Fowler most recently served the U.S. Army in Desert Shield and Desert Storm until April 1991 and that same year was promoted to Brigadier General.  He is the recipient of numerous military awards including the Bronze Star, Saudi Arabian Medal and Desert Shield and Desert Storm Medals.  Dr. Fowler and his wife reside in Chattanooga, Tenn.
    Robert A. Vukovich, Roberts CEO and chairman, stated, "We are very pleased to have such a fine individual elected to the Roberts board. Dr. Fowler's medical background, experience, and his overall business acumen will serve to provide expert input and counsel to Roberts and will add enhanced value to the board's discussions and decisions."
    Roberts Pharmaceuticals is an international pharmaceutical company focusing on the acquisition and development of high-potential, undervalued, late-stage development products and the acquisition of currently marketed prescription and nonprescription products.  Roberts products are currently marketed in seven countries with operating subsidiary companies in the United States, Canada and the United Kingdom.
    -0-             09/30/92
    CONTACT:  Anthony P. Maris of Roberts Pharmaceuticals, 908-389-1182
    (RPCX) CO:  ROBERTS PHARMACEUTICAL CORPORATION IN:  MTC ST:  NJ,TN -- NY055 -- X555  09/30/92
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 30, 1992
Words:416
Previous Article:NEW MICHIGAN BELL PLAN DISCOUNTS CALLS ACROSS AREA CODE
Next Article:JOHNSON CONTROLS ELECTS EXECUTIVE VICE PRESIDENTS
Topics:


Related Articles
ROBERTS PHARMACEUTICAL ELECTS TWO NEW DIRECTORS
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF CHIEF OPERATING OFFICER
ROBERTS PHARMACEUTICAL CORPORATION APPOINTS VICE PRESIDENT, DEVELOPMENTAL THERAPEUTICS
ROBERTS PHARMACEUTICAL CORPORATION ANNOUNCES APPOINTMENT OF NEW GENERAL MANAGER OF CANADIAN SUBSIDIARY
ROBERTS PHARMACEUTICAL CORPORATION ELECTS TWO NEW DIRECTORS
ROBERTS PHARMACEUTICAL CORPORATION EXPANDS EUROPEAN OPERATIONS BY ESTABLISHMENT OF FRENCH SUBSIDIARY - APPOINTS MANAGING DIRECTOR
ROBERTS PHARMACEUTICAL CORPORATION NAMES FORMER CHIEF EXECUTIVE OF BOEHRINGER-INGELHEIM (USA), D.W. BARRIOS, TO ROBERTS BOARD OF DIRECTORS
Roberts Pharmaceutical Corporation Announces Management Addition to Newly Created Position of Senior Vice President, Medical and Regulatory Affairs
Roberts Pharmaceutical Corporation Announces Decision of Its Founder to Retire.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters